Cirsilineol reduces inflammation and apoptosis in an in vitro model of acute pancreatitis

Acute pancreatitis (AP) is a severe inflammatory disorder for which effective treatments are currently lacking. Cirsilineol (CSL), a flavonoid derived from Artemisia plants, is recognized for its potent anti-inflammation and antioxidant characteristics. The mechanisms underlying AP and potential therapeutic agents remain unknown. This study investigates the effects of CSL on AP and delves into its underlying mechanism. Our results indicate that CSL significantly improved cell viability in AR42J pancreatic acinar cells and influenced the levels of pro-inflammatory cytokines. Furthermore, CSL markedly decreased apoptosis markers and inhibited the Nuclear Factor kappa-B (NF-κB) activation by reducing phosphorylation of p65 and inhibitor of NF-κB alpha (IκBα). These findings underscore the powerful anti-inflammatory and anti-apoptotic properties of CSL, acting through the NF-κB pathway, indicating its promise as a therapeutic option for AP.

Cirsilineol; Acute pancreatitis; Inflammation; Apoptosis; NF-κB signaling

[1] Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021; 325: 382–390.

[2] Szatmary P, Grammatikopoulos T, Cai W, Huang W, Mukherjee R, Halloran C, et al. Acute pancreatitis: diagnosis and treatment. Drugs. 2022; 82: 1251–1276.

[3] Lankisch PG, Apte M, Banks PA. Acute pancreatitis. The Lancet. 2015; 386: 85–96.

[4] Lee PJ, Papachristou GI. New insights into acute pancreatitis. Nature Reviews Gastroenterology & Hepatology. 2019; 16: 479–496.

[5] Patel DK. Health benefits, therapeutic applications, and recent advances of cirsilineol in the medicine: potential bioactive natural flavonoids of genus Artemisia. Endocrine, Metabolic & Immune Disorders Drug Targets. 2023; 23: 894–907.

[6] Kim C, Kim GO, Bae JS. Cirsilineol treatment attenuates PM2.5-induced lung injury in mice. International Journal of Molecular Sciences. 2022; 23: 13948.

[7] Wahab S, Alsayari A, Muhsinah AB, Ahmad I, Hussain MS, Mallick J. Cirsilineol inhibits the proliferation of human prostate cancer cells by inducing reactive oxygen species (ROS)-mediated apoptosis. Evidence-Based Complementary and Alternative Medicine. 2022; 2022: 7975664.

[8] Wang C, Zeng R, Li Y, He R. Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NF-kb/ERK/p38 signaling pathways. Chinese Medicine. 2024; 19: 69.

[9] Kim GO, Heo JB, Park DH, Song GY, Bae JS. Antiplatelet aggregation properties of cirsilineol: a novel inhibitor of blood coagulation factor Xa. Pharmaceuticals. 2023; 16: 588.

[10] Wang X, Qian J, Meng Y, Wang P, Cheng R, Zhou G, et al. Salidroside ameliorates severe acute pancreatitis-induced cell injury and pyroptosis by inactivating Akt/NF-kB and caspase-3/GSDME pathways. Heliyon. 2023; 9: e13225.

[11] Zhang P, Yin X, Wang X, Wang J, Na G, Ирина Павловна К. Paeonol protects against acute pancreatitis by Nrf2 and NF-kB pathways in mice. Journal of Pharmacy and Pharmacology. 2022; 74: 1618–1628.

[12] Kim GO, Park DH, Bae JS. Protective effects of cirsilineol against lipopolysaccharide-induced inflammation; insights into HO-1, COX-2, and iNOS modulation. International Journal of Molecular Sciences. 2023; 24: 8537.

[13] Liu Y, Cui H, Mei C, Cui M, He Q, Wang Q, et al. Sirtuin4 alleviates severe acute pancreatitis by regulating HIF-1a/HO-1 mediated ferroptosis. Cell Death & Disease. 2023; 14: 694.

[14] Nagy-Penzes M, Hajnady Z, Regdon Z, Demény MÁ, Kovács K, El-Hamoly T, et al. Tricetin reduces inflammation and acinar cell injury in cerulein-induced acute pancreatitis: the role of oxidative stress-induced DNA damage signaling. Biomedicines. 2022; 10: 1371.

[15] Guangzhen Zhao JJ. HOMER1A restores sevoflurane-induced cognitive dysfunction by regulating microglia’s activation through activating the AMPK/TXNIP axis. Signa Vitae. 2023; 19: 202–212.

[16] Luan Y, Luan Y, Jiao Y, Liu H, Huang Z, Feng Q, et al. Broadening horizons: exploring mtDAMPs as a mechanism and potential intervention target in cardiovascular diseases. To be published in Aging and Disease. 2023. [Preprint].

[17] Lan WP, Guo W, Zhou X, Li Z. Research trends on traditional Chinese medicine and acute pancreatitis: a bibliometric analysis from 2007 to mid-2023. Heliyon. 2024; 10: e25659.

[18] Li L, Liu Q, Le C, Zhang H, Liu W, Gu Y, et al. Toll-like receptor 2 deficiency alleviates acute pancreatitis by inactivating the NF-kB/NLRP3 pathway. International Immunopharmacology. 2023; 121: 110547.

[19] Pan C, Zhang C, Li Y, Cao J, Liang S, Fang H, et al. Studies related to the involvement of EsA in improving intestinal inflammation in acute pancreatitis via the NF-kB pathway. Mediators of Inflammation. 2024; 2024: 9078794.

[20] Ali BM, Al-Mokaddem AK, Selim H, Alherz FA, Saleh A, Hamdan AME, et al. Pinocembrin’s protective effect against acute pancreatitis in a rat model: the correlation between TLR4/NF-kB/NLRP3 and miR-34a-5p/SIRT1/Nrf2/HO-1 pathways. Biomedicine & Pharmacotherapy. 2024; 176: 116854.